[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review

December 2020 | 40 pages | ID: AB566D66C5EFEN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

AMAG Pharmaceuticals Inc (AMAG) is a pharmaceutical company focused on the development and commercialization of specialty pharmaceutical products in therapeutic areas like maternal, women's health, anemia management and hematology. Its products portfolio include Makena an auto-injector device, Feraheme for intravenous, Intrarosa for vaginal inserts and Vylees an auto-injector device. The company is developing two product pipelines; Ciraparantag is in Phase 2b trial of healthy volunteers and AMAG-423 is in phase 2b/3a trial. The company offers its products through a direct sales force and a network of distributors. AMAG is headquartered in Waltham, Massachusetts, the US.

AMAG Pharmaceuticals Inc Key Recent Developments

Oct 02,2020: Covis Group to acquire AMAG Pharmaceuticals for $647m
Aug 06,2020: AMAG Pharmaceuticals announces second quarter 2020 financial results and provides corporate update
Jun 12,2020: AMAG Pharmaceuticals to lay off 35 workers at Waltham, Massachusetts site
Jun 11,2020: AMAG Pharmaceuticals announces leadership changes
May 12,2020: AMAG Pharmaceuticals to lay off 32 workers at Waltham, Massachusetts site

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
List of Tables
List of Figures

SECTION 1 - ABOUT THE COMPANY

AMAG Pharmaceuticals Inc - Key Facts
AMAG Pharmaceuticals Inc - Key Employees
AMAG Pharmaceuticals Inc - Key Employee Biographies
AMAG Pharmaceuticals Inc - Major Products and Services
AMAG Pharmaceuticals Inc - History
AMAG Pharmaceuticals Inc - Company Statement
AMAG Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
AMAG Pharmaceuticals Inc - Business Description
Product Category: Feraheme
Performance
Product Category: Intrarosa
Performance
Product Category: Makena
Performance
Product Category: Other
Performance
R&D Overview
AMAG Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
AMAG Pharmaceuticals Inc - Strengths
AMAG Pharmaceuticals Inc - Weaknesses
AMAG Pharmaceuticals Inc - Opportunities
AMAG Pharmaceuticals Inc - Threats
AMAG Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Aug 06, 2020: AMAG Pharmaceuticals announces second quarter 2020 financial results and provides corporate update
Jun 12, 2020: AMAG Pharmaceuticals to lay off 35 workers at Waltham, Massachusetts site
Jun 11, 2020: AMAG Pharmaceuticals announces leadership changes
May 12, 2020: AMAG Pharmaceuticals to lay off 32 workers at Waltham, Massachusetts site
May 11, 2020: AMAG Pharmaceuticals announces first quarter 2020 financial results and provides corporate update
Apr 28, 2020: AMAG Pharmaceuticals appoints Scott Myers as president and chief executive officer
Apr 16, 2020: AMAG Pharmaceuticals provides COVID-19 company update
Mar 04, 2020: AMAG Pharmaceuticals announces changes to medical development organization
Mar 04, 2020: AMAG Pharmaceuticals reports fourth quarter and full year 2019 financial results and provides corporate update
Jan 09, 2020: AMAG Pharmaceuticals announces leadership transition, results of strategic review to unlock shareholder value and financial update

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

AMAG Pharmaceuticals Inc, Key Facts
AMAG Pharmaceuticals Inc, Key Employees
AMAG Pharmaceuticals Inc, Key Employee Biographies
AMAG Pharmaceuticals Inc, Major Products and Services
AMAG Pharmaceuticals Inc, History
AMAG Pharmaceuticals Inc, Other Locations
AMAG Pharmaceuticals Inc, Subsidiaries
AMAG Pharmaceuticals Inc, Key Competitors
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Recent Deals Summary

LIST OF FIGURES

AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
AMAG Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Teva Pharmaceuticals USA Inc
Slayback Pharma LLC
Sanofi-Aventis US LLC
Keryx Biopharmaceuticals Inc
Fresenius Medical Care North America
American Regent Laboratories, Inc.
American Regent Inc
AMAG Securities Corporation
Allergan USA Inc
Akebia Therapeutics Inc


More Publications